501 related articles for article (PubMed ID: 12742989)
1. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
2. Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Yoshikawa E; Nishina T; Miyazaki M; Ikeda T; Komeda M
Eur J Cardiothorac Surg; 2008 Jan; 33(1):25-31. PubMed ID: 18054245
[TBL] [Abstract][Full Text] [Related]
3. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
[TBL] [Abstract][Full Text] [Related]
4. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
5. Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase.
Liu W; Chen J; Xu T; Tian W; Li Y; Zhang Z; Li W
Am J Hypertens; 2012 Feb; 25(2):250-60. PubMed ID: 22089109
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
Batlle M; Roig E; Perez-Villa F; Lario S; Cejudo-Martin P; García-Pras E; Ortiz J; Roqué M; Orús J; Rigol M; Heras M; Ramírez J; Jimenez W
J Heart Lung Transplant; 2006 Sep; 25(9):1117-25. PubMed ID: 16962475
[TBL] [Abstract][Full Text] [Related]
7. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
[TBL] [Abstract][Full Text] [Related]
8. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.
Takai S; Jin D; Sakaguchi M; Katayama S; Muramatsu M; Sakaguchi M; Matsumura E; Kim S; Miyazaki M
J Pharmacol Exp Ther; 2003 Apr; 305(1):17-23. PubMed ID: 12649348
[TBL] [Abstract][Full Text] [Related]
9. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
Howard PS; Renfrow D; Schechter NM; Kucich U
Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation.
Su X; Wei CC; Machida N; Bishop SP; Hankes GH; Dillon RA; Oparil S; Dell Italia LJ
J Mol Cell Cardiol; 1999 May; 31(5):1033-45. PubMed ID: 10339353
[TBL] [Abstract][Full Text] [Related]
11. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?
Kokkonen JO; Lindstedt KA; Kovanen PT
Circulation; 2003 May; 107(20):2522-4. PubMed ID: 12777313
[No Abstract] [Full Text] [Related]
12. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
Miyazaki M; Takai S; Jin D; Muramatsu M
Pharmacol Ther; 2006 Dec; 112(3):668-76. PubMed ID: 16837049
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
[TBL] [Abstract][Full Text] [Related]
15. Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs.
Jin D; Ueda H; Takai S; Okamoto Y; Muramatsu M; Sakaguchi M; Shibahara N; Katsuoka Y; Miyazaki M
J Am Soc Nephrol; 2005 Apr; 16(4):1024-34. PubMed ID: 15744002
[TBL] [Abstract][Full Text] [Related]
16. Chymase mediates paraquat-induced collagen production in human lung fibroblasts.
Lang YD; Chang SF; Wang LF; Chen CM
Toxicol Lett; 2010 Mar; 193(1):19-25. PubMed ID: 19969051
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
[TBL] [Abstract][Full Text] [Related]
18. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H; Ganten D
Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
[TBL] [Abstract][Full Text] [Related]
19. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A
J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]